Prophylaxis With Intrathecal or High-Dose Methotrexate Reduces the Risk of CNS Relapse in DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Cancer Journal
Prophylaxis With Intrathecal or High-Dose Methotrexate in Diffuse Large B-Cell Lymphoma and High Risk of CNS Relapse
Blood Cancer J 2021 Jun 16;[EPub Ahead of Print], S Bobillo, E Joffe, D Sermer, et alBrain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.